EyePoint's eye drug misses main goal in late-stage trial

EyePoint said ​on Monday its ‌experimental eye drug failed to meet its main ​goal in ​a late-stage trial.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。